MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2337/dc25-1178

Медицинская библиотека · Diabetes care · 2025

Effects of Modern Glucose Monitoring and Insulin Delivery Technologies on Patient-Reported Outcomes and Experiences in Individuals With Type 1 Diabetes: A Systematic Review and Meta-analysis.

Gao Miao, Saravanan Swathi, Munyombwe Theresa, Speight Jane, Hill Andrew J, Traviss-Turner Gemma, Ajjan Ramzi A

СтатьяСистематический обзорМетаанализПеревод в очереди

Аннотация

BACKGROUND

Use of technology is central to the management of type 1 diabetes (T1D), while patient reported outcomes measures (PROMs) can support in the management of these individuals.

PURPOSE: To assess the effect of diabetes technologies on patient-reported outcome measures (PROMs) in type 1 diabetes (T1D).

DATA SOURCES: Cochrane Library CENTRAL, Embase, MEDLINE, Scopus, and Web of Science were searched for relevant articles from 2013 to August 2025.

STUDY SELECTION: We included longitudinal diabetes technology studies assessing validated PROMs in nonpregnant adults with T1D.

DATA EXTRACTION: Study characteristics and PROM data were extracted, and standardized mean differences (SMDs) for PROs were pooled using a random-effects meta-analysis.

DATA SYNTHESIS: We identified 4,885 articles, comprising 81 independent studies (n = 19,148 participants) and 70 different PROMs. The Hypoglycemia Fear Survey (HFS) was most commonly used (k = 39 studies), followed by the Diabetes Treatment Satisfaction Questionnaire (status [DTSQs] or change version [DTSQc]; k = 38), Diabetes Distress Scale (DDS; k = 25), and Problem Areas in Diabetes (PAID) scale (k = 24). Technology use was associated with lower HFS total score compared with control (SMD -0.177; 95% CI -0.319, -0.036; P = 0.014; I2 = 0.0%), with the largest effect observed in automated insulin device users. A moderate positive effect of diabetes technologies was observed on DTSQs and DTSQc scores (SMD 0.429; 95% CI 0.206, 0.653; P < 0.001; I2 = 72.3%), with a small to moderate reduction in DDS and PAID scores (SMD -0.265; 95% CI -0.363, -0.166; P < 0.001; I2 = 0.0%).

LIMITATIONS: Differences in type of technology, varied use and incomplete reporting of PROMs, and different duration of studies.

CONCLUSIONS

Diabetes technologies offer psychological benefits in adults with T1D. The large number of reported PROMs suggests a need to standardize their use.

Для цитирования: Gao Miao, Saravanan Swathi, Munyombwe Theresa, Speight Jane, Hill Andrew J, Traviss-Turner Gemma, Ajjan Ramzi A. Effects of Modern Glucose Monitoring and Insulin Delivery Technologies on Patient-Reported Outcomes and Experiences in Individuals With Type 1 Diabetes: A Systematic Review and Meta-analysis.. Diabetes care. 2025. DOI: 10.2337/dc25-1178.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.